| 摘要 |
<p>The invention relates to a solid pharmaceutical composition comprising telithromycin or one of the addition salts thereof with a pharmaceutically-acceptable acid as an active principle. The invention is characterised in that the composition comprises the following components in relation to the total weight of the composition: between 0.1 and 80 wt.-% telithromycin or one of the addition salts thereof with a pharmaceutically-acceptable acid, and between 10 and 50 wt.-% of at least one diluent with a plastic behaviour. Advantageously, the invention takes the form of a telithromycin tablet having a noticeably-reduced size but providing an identical dosage of telithromycin and displaying improved mechanical properties.</p> |
